---
title: "Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial."
date: 2022-06-18 00:00:00 -0700
enddate:
---

Published in: *Nature medicine*

DOI: 10.1038/s41591-022-01866-4

<img src=https://upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/800px-Open_Access_logo_PLoS_transparent.svg.png alt="drawing" width="40" align="left"/> &nbsp This publication is available in <strong>Open Access</strong>! (Hybrid OA)

&nbsp;&nbsp;&nbsp;[Access it freely here](https://www.nature.com/articles/s41591-022-01866-4.pdf
)

